The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 11, 2022

Filed:

Mar. 05, 2018
Applicant:

Nordmark Pharma Gmbh, Uetersen, DE;

Inventors:

Richard Fuhrherr, Uetersen, DE;

Jan Lüdemann, Uetersen, DE;

Lisa Garrett, Wiltshire, GB;

Assignee:

Nordmark Pharma GmbH, Uetersen, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/46 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 9/19 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/42 (2017.01);
U.S. Cl.
CPC ...
A61K 38/465 (2013.01); A61K 9/0056 (2013.01); A61K 9/0095 (2013.01); A61K 9/08 (2013.01); A61K 9/19 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/42 (2013.01); C12Y 301/01003 (2013.01);
Abstract

The present invention relates to an orodispersible tablet characterized in that it includes burlulipase. It also relates to liquid pharmaceutical compositions that contain solutions of such orodispersible tablets in water or other beverages. It relates to drugs that contain or consist of such orodispersible tablets or solutions. In particular, it relates to such drugs that are suitable for treating digestive problems, in particular exocrine pancreatic insufficiency used to treat digestive problems. In particular, they are for the treatment of exocrine pancreatic insufficiency in cystic fibrosis patients and for treatment of exocrine pancreatic insufficiency in pediatric patients.


Find Patent Forward Citations

Loading…